Literature DB >> 25999220

Erythema migrans.

Robert B Nadelman1.   

Abstract

Erythema migrans (EM) is the most common objective manifestation of Borrelia burgdorferi infection. Systemic symptoms are usually present. Most patients do not recall a preceding tick bite. Despite a characteristic appearance, EM is not pathognomonic for Lyme disease and must be distinguished from other similar appearing skin lesions. EM is a clinical diagnosis; serologic and PCR assays are unnecessary. Leukopenia and thrombocytopenia are indicative of either an alternative diagnosis, or coinfection with another tick-borne pathogen. When EM is promptly treated with appropriate antimicrobial agents, the prognosis is excellent. Persons in endemic areas should take measures to prevent tick bites.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Borrelia burgdorferi; Erythema migrans; Lyme disease

Mesh:

Substances:

Year:  2015        PMID: 25999220     DOI: 10.1016/j.idc.2015.02.001

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  13 in total

Review 1.  Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?

Authors:  Emir Hodzic
Journal:  Bosn J Basic Med Sci       Date:  2015-07-08       Impact factor: 3.363

2.  Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples.

Authors:  Adoracion Pegalajar-Jurado; Martin E Schriefer; Ryan J Welch; Marc R Couturier; Tiffany MacKenzie; Rebecca J Clark; Laura V Ashton; Mark J Delorey; Claudia R Molins
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

Review 3.  Challenges in the Diagnosis and Treatment of Lyme Disease.

Authors:  Robert T Schoen
Journal:  Curr Rheumatol Rep       Date:  2020-01-07       Impact factor: 4.592

4.  Metabolic differentiation of early Lyme disease from southern tick-associated rash illness (STARI).

Authors:  Claudia R Molins; Laura V Ashton; Gary P Wormser; Barbara G Andre; Ann M Hess; Mark J Delorey; Mark A Pilgard; Barbara J Johnson; Kristofor Webb; M Nurul Islam; Adoracion Pegalajar-Jurado; Irida Molla; Mollie W Jewett; John T Belisle
Journal:  Sci Transl Med       Date:  2017-08-16       Impact factor: 17.956

5.  Common Dermatologic Conditions in Returning Travelers.

Authors:  Zachary Shepard; Margarita Rios; Jamie Solis; Taylor Wand; Andrés F Henao-Martínez; Carlos Franco-Paredes; José Antonio Suarez
Journal:  Curr Trop Med Rep       Date:  2021-02-16

6.  Erythema migrans associated with partial Horner's syndrome.

Authors:  Isha Verma; Abhinav Agrawal
Journal:  BMJ Case Rep       Date:  2015-12-07

7.  Lyme Disease in Humans.

Authors:  Justin D Radolf; Klemen Strle; Jacob E Lemieux; Franc Strle
Journal:  Curr Issues Mol Biol       Date:  2020-12-11       Impact factor: 2.081

8.  Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005-2014.

Authors:  Karen O Johnson; Mark P Nelder; Curtis Russell; Ye Li; Tina Badiani; Beate Sander; Douglas Sider; Samir N Patel
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

9.  Identification of Urine Metabolites as Biomarkers of Early Lyme Disease.

Authors:  Adoracion Pegalajar-Jurado; Bryna L Fitzgerald; M Nurul Islam; John T Belisle; Gary P Wormser; Kathlene S Waller; Laura V Ashton; Kristofor J Webb; Mark J Delorey; Rebecca J Clark; Claudia R Molins
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379

10.  The continued rise of Lyme disease in Ontario, Canada: 2017.

Authors:  M P Nelder; S Wijayasri; C B Russell; K O Johnson; A Marchand-Austin; K Cronin; S Johnson; T Badiani; S N Patel; D Sider
Journal:  Can Commun Dis Rep       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.